Nalaganje...
Fulminant type 1 diabetes mellitus induced by pembrolizumab in a patient with urothelial carcinoma: A case report
A case of fulminant type 1 diabetes mellitus secondary to administration of pembrolizumab in a patient with urothelial carcinoma is presented. Eight days after the third infusion of pembrolizumab, the patient presented with complaints of malaise and anorexia. The patient's laboratory data showe...
Shranjeno v:
| izdano v: | Urol Case Rep |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6562295/ https://ncbi.nlm.nih.gov/pubmed/31211060 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eucr.2019.100849 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|